| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |